metabolic syndrome, incidence of diabetes and mortality among elderly: the italian longitudinal...
TRANSCRIPT
METABOLIC SYNDROME, INCIDENCE OF DIABETES
AND MORTALITY AMONG ELDERLY: THE ITALIAN LONGITUDINAL STUDY ON
AGING
M Noale, S Maggi, F Limongi, P Siviero, G Romanato, G CrepaldiCNR, Institute of Neuroscience, Padova (Italy)
MGSD 2011 Casablanca, Morocco
• The Metabolic Syndrome (MetS) is a clustering of metabolic and physiologic disorders, affecting an important part of the Italian elderly population: results from the ILSA study show that it is present in 31.5% of older men and 59.8% of older women.
• Because of its association with insulin resistance, subjects with MetS are more likely to have type 2 diabetes (T2D).
• The aim of the present work is to investigate if MetS can predict incidence of T2D and if it exists a synergic association MetS-T2D and all-cause mortality among elderly subjects.
MATERIAL AND METHODS
• The analyses are based on data collected by the Italian Longitudinal Study on Aging (ILSA):
• Logistic regression models were defined to study the influence of MetS on incidence of T2D, adjusting for age, sex, individual Mets components.
• Data on mortality collected between baseline and 1996 follow-up were considered, and Cox Ph Models defined to determine the death risk attributation to the synergic association of MetS and T2D.
Sample (Maggi et al, 1994) : 5,632 free-dwelling and institutionalised individuals aged 65-84 resident in 8 centers randomly selected from the local anagraphic lists, equal allocation by sex and 5-year-age groups with two phases
Screening phase, with personal interview, laboratory test, and diagnostic tests (MMSE, neurological tests, GDS, ADL, IADL, spirometry, retinography, electrocardiography)
Clinical confirmation by geriatrician or neurologist for those subjects screened positive for heart failure, angina, arrhythmia, hypertension, myocardial infarction, diabetes, stroke, parkinsonism, distal symmetric neuropathy of lower limbs, dementia
MILANO
GENOVA
FIRENZE
PADOVA
FERMO
NAPOLI
CATANIA
BARI
RESULTSINCIDENCE OF DIABETES
Subjects without T2D at baseline(n=2,660)
42,553,1
34,140,6
14,7
89
0
20
40
60
80
100
%
MetS
Abdominal obesity (>102 men; >88 women)
Plasma triglycerides (>=1,69 mmol/L)
HDL (<1.04 mmol/l men, <1.29 women)
Fasting glucose (>=6.1 mmol/l)
Systolic blood pressure (>=130 mm Hg) or diastolic bloodpressure (>=85 mm Hg), or treated with hypertensive
INCIDENT CASES OF DIABETES
(n=68)OR 95% CI p-value
Metabolic syndrome
3.00
1.14-7.85 0.0255
Abdominal obesity
1.50
0.70-3.18 0.2955
Triglycerides 0.57
0.32-1.02 0.0573
HDL cholesterol 0.58
0.31-1.08 0.0842
Fasting Glucose 9.12
4.98-16.7 <0.0001
Blood pressure 1.98
0.41-9.54 0.3954
(model adjusted for age, sex, individual MetS criteria)
RESULTSALL CAUSE MORTALITY
Subjects with or without diabetes at baseline (n=3,081)
Subjects without diabetes and MetS
(T2D- MetS-, n=1,529)
Subjects with diabetes but without MetS
(T2D+ MetS- n=92)
Subjects without diabetes but with MetS
(T2D- MetS+ n=1,132)
Subjects with diabetes and MetS
(T2D+ MetS+, n=328)
ALL CAUSE MORTALITY
(n=297 death)HR 95% CI p-value
T2D – MetS - 1.00 - -T2D + MetS - 2.26 0.95-5.41 0.0661T2D – MetS + 1.13 0.58-2.18 0.7211T2D + MetS
+2.68 1.10-6.55 0.0307
(model adjusted for age, sex, individual MetS criteria, education, smoking status, marital status, hypertension, myocardial infarction, heart failure, angina, ictus, distal symmetric neuropathy, arrhythmia, disability in ADL, disability in IADL)
CONCLUSION
MetS is associated with incidence of T2D, and the synergic association MetS-T2D is an important risk factor for all-cause mortality among elderly subjects.